C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/233, 260/312
C07D 257/04 (2006.01) A61K 31/41 (2006.01)
Patent
CA 1303049
ABSTRACT OF THE DISCLOSURE A new compound, 3-(1H-tetrazol-5-yl)oxanilic acid and pharmaceutically acceptable salts thereof are herein disclosed, which can be prepared by reacting 3-(1H-tetrazol-5- yl)aniline with a compound represented by the general formula: A-CO-CO-B (wherein A and B may be identical with or different from one another and represent hydroxyl group, a halogen atom or a lower alkoxy group) and then optionally hydrolyzing the resultant product. The compound presents an excellent histamine and SRS-A release inhibitory effect and is hydrophilic or soluble in water. Therefore, the compound is very suitable to form, in particular, an aqueous pharmaceuticals for treatment or prevention of allergic diseases such as bronchial asthma, rhinitis and conjunctivitis.
543888
Abe Tooru
Hashimoto Terumasa
Horio Yoshihiro
Ootake Yasuhiro
Sawaki Shohei
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Wakamoto Pharmaceutical Co. Ltd.
LandOfFree
3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1333444